Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.

By D. Wood, F. Palace. European Heart Journal, 2001

931 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Surgery

View Paper: https://www.semanticscholar.org/paper/b64b72ae0f9f5b17c1778854429c93ffa36c4166

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. A. Vahanian

Citations in the corpus

• European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) (2012, neutral): “Moreover, the changes between EUROASPIRE I (1996) and EUROASPIRE III reveal that the proportion of smokers did not change and BP control has not improved despite increased use of antihypertensive drugs, while the number of patients with (central) obesity continues to increase.”
• A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. (2003, background): “Previous surveys have been conducted in the field of prevention, heart failure and acute coronary syndromes.(2,3)”